» Articles » PMID: 29593291

Structural Insights into the RNA Methyltransferase Domain of METTL16

Overview
Journal Sci Rep
Specialty Science
Date 2018 Mar 30
PMID 29593291
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

N-methyladenosine (mA) is an abundant modification in messenger RNA and noncoding RNAs that affects RNA metabolism. Methyltransferase-like protein 16 (METTL16) is a recently confirmed mA RNA methyltransferase that methylates U6 spliceosomal RNA and interacts with the 3'-terminal RNA triple helix of MALAT1 (metastasis-associated lung adenocarcinoma transcript 1). Here, we present two X-ray crystal structures of the N-terminal methyltransferase domain (residues 1-291) of human METTL16 (METTL16_291): an apo structure at 1.9 Å resolution and a post-catalytic S-adenosylhomocysteine-bound complex at 2.1 Å resolution. The structures revealed a highly conserved Rossmann fold that is characteristic of Class I S-adenosylmethionine-dependent methyltransferases and a large, positively charged groove. This groove likely represents the RNA-binding site and it includes structural elements unique to METTL16. In-depth analysis of the active site led to a model of the methyl transfer reaction catalyzed by METTL16. In contrast to the major mA methyltransferase heterodimer METTL3/METTL14, full-length METTL16 forms a homodimer and METTL16_291 exists as a monomer based on size-exclusion chromatography. A native gel-shift assay shows that METTL16 binds to the MALAT1 RNA triple helix, but monomeric METTL16_291 does not. Our results provide insights into the molecular structure of METTL16, which is distinct from METTL3/METTL14.

Citing Articles

Cryo-EM structure of human TUT1:U6 snRNA complex.

Yamashita S, Tomita K Nucleic Acids Res. 2025; 53(2).

PMID: 39831302 PMC: 11734702. DOI: 10.1093/nar/gkae1314.


The mA regulators in prostate cancer: molecular basis and clinical perspective.

Cao Y, Jia M, Duan C, Yang Z, Cheng B, Wang R Front Pharmacol. 2024; 15:1448872.

PMID: 39268470 PMC: 11391310. DOI: 10.3389/fphar.2024.1448872.


Structures and mechanisms of the RNA m A writer.

Deng T, Ma J Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):59-72.

PMID: 39238441 PMC: 11877144. DOI: 10.3724/abbs.2024152.


METTL16 participates in haemoglobin H disease through m6A modification.

Liao Y, Zhang F, Yang F, Huang S, Su S, Tan X PLoS One. 2024; 19(8):e0306043.

PMID: 39088431 PMC: 11293636. DOI: 10.1371/journal.pone.0306043.


RNA Binding by the m6A Methyltransferases METTL16 and METTL3.

Mansfield K Biology (Basel). 2024; 13(6).

PMID: 38927271 PMC: 11200852. DOI: 10.3390/biology13060391.


References
1.
Wang X, Zhao B, Roundtree I, Lu Z, Han D, Ma H . N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell. 2015; 161(6):1388-99. PMC: 4825696. DOI: 10.1016/j.cell.2015.05.014. View

2.
Dorsett M, Westlund B, Schedl T . METT-10, a putative methyltransferase, inhibits germ cell proliferative fate in Caenorhabditis elegans. Genetics. 2009; 183(1):233-47. PMC: 2746148. DOI: 10.1534/genetics.109.105270. View

3.
Brown J, Valenstein M, Yario T, Tycowski K, Steitz J . Formation of triple-helical structures by the 3'-end sequences of MALAT1 and MENβ noncoding RNAs. Proc Natl Acad Sci U S A. 2012; 109(47):19202-7. PMC: 3511071. DOI: 10.1073/pnas.1217338109. View

4.
Linder B, Grozhik A, Olarerin-George A, Meydan C, Mason C, Jaffrey S . Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods. 2015; 12(8):767-72. PMC: 4487409. DOI: 10.1038/nmeth.3453. View

5.
Iwaoka M, Isozumi N . Hypervalent nonbonded interactions of a divalent sulfur atom. Implications in protein architecture and the functions. Molecules. 2012; 17(6):7266-83. PMC: 6269016. DOI: 10.3390/molecules17067266. View